Improving treatments and survivorship for teens and young adults with Hodgkin lymphoma
Advancing novel therapeutics and translational science to close the survivorship gap in pediatric, adolescent and young adult (AYA) lymphoma
This effort will bring newer targeted and immune-based therapies to adolescents and young adults with Hodgkin lymphoma to try to improve survival and reduce long-term side effects.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11166307 on NIH RePORTER |
What this research studies
If you join work stemming from this project, researchers plan to test antibody‑drug conjugates, immunotherapies, and CD30‑targeted cellular approaches in teens and young adults with Hodgkin lymphoma. They will design trials that use emerging tumor and host biology to tailor treatment intensity and follow response. The project links trial data with national epidemiologic and follow‑up data to better understand long‑term outcomes. At Emory and through national collaborations, the team will also work to improve clinical trial access and enrollment for AYA patients.
Who could benefit from this research
Good fit: Adolescents and young adults with newly diagnosed or relapsed/refractory Hodgkin lymphoma who meet eligibility for clinical trials of immunotherapy or CD30‑targeted treatments.
Not a fit: People without Hodgkin lymphoma, those outside the pediatric/AYA age range, or those who are medically ineligible for trial participation likely would not benefit directly from this work.
Why it matters
Potential benefit: Could offer safer, more effective treatment options and better long-term survival and quality of life for adolescents and young adults with Hodgkin lymphoma.
How similar studies have performed: Antibody‑drug conjugates and immune checkpoint therapies have shown benefit in Hodgkin lymphoma in adults, but applying and tailoring these approaches for children and AYAs is still relatively new.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Castellino, Sharon Marie — Emory University
- Study coordinator: Castellino, Sharon Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.